LIMS1 and lung cancer: Overexpression of ILK in lung cancer cells results in the upregulation of PINCH1, β-parvin, and Ras suppressor protein 1 (RSU1) expression, while pharmacologic inhibition of ILK in KRAS-mutant lung cancer cells suppressed cell growth, migration, and EMT [71].